 |
|
Managing Behavior Problems in Nursing Homes
Stephen F. Jencks, MD;
Steven B. Clauser, PhD
JAMA. 1991;265(4):502-503.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
This issue of JAMA contains two disquieting articles on the use of neuroleptics and mechanical restraints in nursing homes. These articles have a special timeliness because of a growing movement, embodied in recent Health Care Financing Administration (HCFA)1 regulations, to transform nursing homes into rehabilitative environments that promote individualized care and the highest practical levels of functioning and independence. A major objective of this movement is to limit the use of medication and mechanical restraints to purposes of medical treatment.
For 15 years, evidence has been accumulating that nursing home residents receive more psychotropic drugs, especially neuroleptics, than is easily explained by good medical practice.2,3 Garrard et al4 confirm previous evidence that the prescribing of neuroleptic drugs is widespread (not news) and show that the reasons for such prescribing are poorly documented (a new finding). Specifically, only half of the neuroleptic therapy used in the study of
. . . [Full Text PDF of this Article]
Author Affiliations
From the Office of Research, Health Care Financing Administration, Baltimore, Md.
Footnotes
The opinions herein are those of the authors and not necessarily the policy of the Health Care Financing Administration.
Reprint requests to Office of Research, Health Care Financing Administration, 6325 Security Blvd, 2-A-12 Oak Meadows, Baltimore, MD 21207 (Dr Jencks).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
